8-K/A: BiomX Inc. Amends Reverse Stock Split Details

BiomX Inc. files an amendment to its 8-K to clarify the treatment of fractional shares following its previously announced one-for-ten reverse stock split.

Summary

• BiomX Inc. has filed an amendment (Form 8-K/A) to its previous report concerning a one-for-ten (1-for-10) reverse stock split.
• This amendment specifically addresses the treatment of fractional shares, stating that no fractional shares will be issued.
• Instead, stockholders entitled to fractional shares will receive one whole share in lieu of the fractional amount, applied at the record holder level.
• For shares held through DTC, rounding will occur at the DTC participant level, not for individual beneficial owners.
• The reverse stock split is set to become effective at 12:01 a.m. Eastern Time on September 9, 2026.
• The company's common stock is expected to trade on a split-adjusted basis on the NYSE American starting September 9, 2026.
• This action reduces the number of outstanding shares from approximately 27.3 million to about 2.7 million.
• Proportionate adjustments will be made to outstanding warrants, convertible instruments, and equity awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, primarily an administrative adjustment to comply with exchange listing requirements rather than a reflection of underlying business performance.

Positives

• The company is proactively addressing potential complexities of the reverse stock split by providing clear guidance on fractional share treatment.
• The reverse stock split aims to increase the per-share market price of the common stock, potentially improving its attractiveness to investors and meeting exchange listing requirements.

Negatives

• The treatment of fractional shares for beneficial owners held in street name may lead to minor changes in their exact percentage ownership, and they will not receive a whole share from the company in lieu of a fractional interest.
• Reverse stock splits are often perceived negatively by the market as they can signal underlying issues with share price performance.

Risks

• Potential for confusion or dissatisfaction among beneficial owners regarding the handling of fractional shares.
• The effectiveness of the reverse stock split is subject to the timely filing and processing of corporate actions by the NYSE American and DTC.
• Risks associated with the company's overall business, as detailed in its Form 10-K for the fiscal year ended December 31, 2025, and Form 10-Q for the quarter ended June 30, 2026, could still impact the stock price.

Future Outlook

The company expects the reverse stock split to become effective on September 9, 2026, with common stock trading on a split-adjusted basis on the NYSE American from that date. Adjustments will be made to outstanding warrants, convertible instruments, and equity awards.

Management Comments

• Stockholders of record who would otherwise be entitled to receive a fractional share will be entitled to receive one whole share of Common Stock in lieu of such fractional share.
• Rounding will be applied at the record holder level.
• For shares held through The Depository Trust Company (DTC), rounding will be applied at the DTC participant level, and not at the level of individual beneficial owners.
• Beneficial owners holding Common Stock in street name will have their positions adjusted by their bank, broker or other nominee in accordance with such nominees own procedures, which may include allocating and holding fractional interests in Common Stock.
• The Company will not issue additional whole shares in respect of fractional interests of individual beneficial owners, and a beneficial owner will not receive a whole share from the Company in lieu of a fractional interest.

Industry Context

StockSavvy.ai notes that reverse stock splits are a common tool for companies, particularly those whose stock price has fallen significantly, to regain compliance with exchange listing requirements (e.g., minimum share price) and potentially improve investor perception. However, they do not address the underlying business fundamentals.

Stakeholder Impact

• Shareholders will see their number of shares reduced by a factor of ten, with their total ownership percentage remaining largely the same, except for minor adjustments due to fractional share treatment.
• Beneficial owners holding shares in street name may experience slight variations in their holdings due to their broker's specific procedures for handling fractional interests.
• Brokers and DTC participants will need to adjust their internal records and systems to reflect the split-adjusted share counts and fractional share allocations.

Next Steps

• The company will file a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware.
• The common stock will begin trading on the NYSE American on a split-adjusted basis on September 9, 2026.
• The company will report the filing and effectiveness of the Certificate of Amendment under Item 5.03 of Form 8-K following the effective time.

Key Dates

Keywords

reverse stock split, fractional shares, BiomX Inc., common stock, NYSE American, stockholder, corporate action, amendment